Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2024 | 10-2023 | 10-2022 | 12-2021 | 10-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,574 | 5,428 | 129 | 137 | 137 |
| Marketable Securities | 289 | 86 | 194 | 205 | 205 |
| Receivables | 181 | 240 | 98 | 104 | 104 |
| Other current assets | 0 | 0 | 0 | 15 | 15 |
| TOTAL | $7,088 | $5,795 | $435 | $461 | $461 |
| Non-Current Assets | |||||
| PPE Net | N/A | 2 | 13 | 14 | 14 |
| Intangibles | 108 | 119 | 130 | 0 | 0 |
| Other Non-Current Assets | 59 | 38 | 249 | 0 | 0 |
| TOTAL | $167 | $159 | $392 | $14 | $14 |
| Total Assets | $7,255 | $5,953 | $826 | $876 | $876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 575 | 659 | 1,604 | 0 | 0 |
| Other current liabilities | 3,520 | 4,310 | 291 | N/A | N/A |
| TOTAL | $4,131 | $4,970 | $1,932 | $2,049 | $2,049 |
| Non-Current Liabilities | |||||
| TOTAL | $16 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,148 | $4,970 | $1,932 | $2,049 | $2,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 82 |
| Common Shares | 24,168 | 17,131 | 6,707 | N/A | N/A |
| Retained earnings | -24,023 | -18,768 | -10,147 | -10,759 | -10,759 |
| Other shareholders' equity | 2,962 | 2,620 | 2,335 | 9,586 | 9,586 |
| TOTAL | $3,108 | $984 | $-1,106 | $-1,173 | $-1,173 |
| Total Liabilities And Equity | $7,256 | $5,953 | $826 | $876 | $876 |